Life sciences news
-
Mayne Pharma and Mithra announce US launch of HALOETTE®, a generic version of NUVARING®
Friday January 13th 2023
Read more
-
FINTEPLA®▼ (fenfluramine) oral solution recommended for approval in the EU for adjunctive treatment of seizures associated with Lennox-Gastaut syndrome (LGS)
Monday December 19th 2022
Read more
-
New Idylla™ EGFR study shows reduction of time-to-treatment by 48% for lung cancer patients
Tuesday November 8th 2022
Read more
-
Biocartis initiates commercialization in Europe of HepatoPredict (CE-IVD) test for liver cancer patients
Monday October 10th 2022
Read more
-
IBA and SCK CEN launch Pantera, a joint-venture to produce actinium-225
Thursday September 22nd 2022
Read more
-
New three-year BIMZELX®▼ (bimekizumab) data reinforce long-term maintenance of complete skin clearance in moderate to severe plaque psoriasis
Wednesday September 7th 2022
Read more
-
Biocartis initiates commercialization in Europe of SkylineDx’s innovative Merlin™ Assay (CE-IVD) for melanoma patients
Thursday September 1st 2022
Read more
-
argenx announces European Commission approval of VYVGART™ (efgartigimod alfa-fcab) for the treatment of generalized myasthenia gravis
Thursday August 11th 2022
Read more
-
Your news here?
-
ANeuroTech receives positive feedback from the FDA for its pivotal Phase IIIb development programme for ANT-01 as an adjunctive anti-depression drug for Major Depressive Disorder
Tuesday July 5th 2022
Read more
-
New agreement paves way for development of first African-owned COVID-19 vaccine
Tuesday June 21st 2022
Read more
-
argenx announces the UK MHRA has granted early access to efgartigimod for generalized myasthenia gravis
Tuesday May 31st 2022
Read more
More info?
Contact us
Ellen Telleir
Communication Coordinator